MAYO CLINIC ROCHESTER
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) is a funding opportunity from MAYO CLINIC ROCHESTER, up to 17009244, closing August 31, 2030.
Aug 31, 2030
(1492d left)Overview
ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein tau (i.e.,…